CARIPRAZINE vs CASIRIVIMAB\IMDEVIMAB: Which Drug Is Safer?
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
CARIPRAZINE vs CASIRIVIMAB\IMDEVIMAB: Safety Overview
| Metric | CARIPRAZINE | CASIRIVIMAB\IMDEVIMAB |
|---|---|---|
| Total FAERS Reports | 6,547 | 4,248 |
| Deaths Reported | 194 | 137 |
| Death Rate | 3.0% | 3.2% |
| Hospitalizations | 702 | 1,351 |
| Average Patient Age | 40.4 yrs | 54.3 yrs |
| % Female Patients | 64.0% | 55.4% |
| FDA Approval Date | Dec 16, 2025 | N/A |
| Manufacturer | Allergan, Inc. | N/A |
| Route | ORAL | N/A |
| Marketing Status | Prescription | N/A |